Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02536365 · ClinicalTrials.gov registry record · NA
Sensory Integration Therapy in Autism: Mechanisms and Effectiveness
A NA study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 135
- Enrollment target
NCT02536365 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 135 participants.
The verdict
NCT02536365, a NA study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 135 participants
- Enrollment target
Study Summary
A common feature of ASD is over or under sensitivity to the environment and difficulty putting sensory information together in an orderly way, referred to here as sensory issues. Building on previous work, this study will test the efficacy of Sensory Integration Therapy (SIT), a non-invasive intervention to improve functional skills in children with ASD, in comparison to commonly applied ABA behavioral treatments, in the treatment of ASD symptoms. A total of 180 children with ASD and sensory issues in the greater New York City Metropolitan area will complete this study.
Interventions
- BEHAVIORAL Sensory Integration Therapy
- BEHAVIORAL Applied Behavioral Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2015-09 |
| Est. Completion | 2022-10-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02536365
The ClinicalTrials.gov registry entry for NCT02536365 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sensory Integration Therapy is the first listed.
NCT02536365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02536365 about?
NCT02536365 is a clinical study titled "Sensory Integration Therapy in Autism: Mechanisms and Effectiveness". A common feature of ASD is over or under sensitivity to the environment and difficulty putting sensory information together in an orderly way, referred to here as sensory issues. Building on previous work, this study will test the efficacy of Sensory Integration Therapy (SIT), a non-invasive interve...
What is the current status of trial NCT02536365?
This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2015-09. Estimated completion is 2022-10-15.
What interventions are being tested in trial NCT02536365?
The interventions under investigation include: Sensory Integration Therapy (BEHAVIORAL), Applied Behavioral Analysis (BEHAVIORAL).
Who is sponsoring clinical trial NCT02536365?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.